The Knight Cardiovascular Institute invites you to attend “OregonHeart: Developing a total artificial heart,” a lecture providing an overview of the KCVI’s new company aimed at developing a successful total artificial heart device to treat patients with end-stage heart failure. OregonHeart’s Chief Scientific Officer and renowned inventor of the Hemopump, Richard Wampler, will present, along with other company representatives and OHSU faculty collaborators. Thursday, May 28, 2015 5 to 6:30 p.m. Collaborative Life Sciences Building, … Read More
Posts Tagged ‘OHSU Knight Cardiovascular Institute’
The fourth annual OHSU Stroke Conference will take place this year on Saturday, Mar. 7, 2015, from 9 a.m. to 5:30 p.m. in the Collaborative Life Science Building (CLSB). This one-day annual conference brings together OHSU clinicians and scientists interested in stroke, cerebrovascular disease and traumatic brain injury to share their expertise, report on scientific progress, and discuss research collaborations. This year’s event is hosted by Nabil Alkayed, M.D., Ph.D., professor and vice chair, Anesthesiology … Read More
Chittaranjan Yajnik, M.D., FRCP, an international expert in the field of developmental origins of disease, has been invited by the School of Medicine Research Roadmap and the Knight Cardiovascular Institute Center for Developmental Health’s David J.P. Barker Memorial Lecture Series to give a lecture during Research Week on Thursday, May 8, from 12 to 1 p.m. in the OHSU Auditorium. Dr. Yajnik will lead us in a conversation about the rapidly rising epidemic of diabetes and non-communicable … Read More
In a paper published March 4 in Nature Communications, coauthored by Lincoln Shenje, M.D., Ph.D, assistant professor at the OHSU Knight Cardiovascular Institute, researchers describe the first found gene mutation in humans that causes heart muscle cells to proliferate beyond birth. This mutation was discovered in a rare syndrome called ALMS1 that has been reported in less than 70 people in the past 50 years worldwide. According to Dr. Shenje and colleagues, this discovery goes … Read More
The Fluidigm Corporation will be presenting on their single-cell genomics technology; an overview of the field of single-cell genomics and examples of applications on Friday, November 8 from 10 to 11 a.m. in Mac Hall 3189. This technology is currently deployed in the lab of Dr. Lincoln Shenje of the Knight Cardiovascular Institute. This research capability is made possible by the generous donation from the Knight Family, and this is one of the numerous ways in … Read More
Last week, Albert Starr, M.D., and Sanjiv Kaul, M.D., co-directors of the new OHSU Knight Cardiovascular Institute, published a letter to update the OHSU community on the progress of the institute. Included in this update is a discussion of potential “signature research themes” for the Knight Cardiovascular Institute. We encourage you to read the full letter in the School of Medicine Research Voice.
In September we announced a historic $125 million gift from Phil and Penny Knight to establish a new cardiovascular institute at OHSU. This week, the institute was officially named the OHSU Knight Cardiovascular Institute. Under the leadership of Albert Starr, M.D. and Sanjiv Kaul, M.D., the institute will aim to be a world leader in translational cardiovascular research. This gift comes four years after the creation of the OHSU Knight Cancer Institute, which thanks to … Read More